Published in Bone Marrow Transplant on June 01, 2004
Pathogenesis of thrombotic microangiopathies. Annu Rev Pathol (2008) 1.69
Inhibitory autoantibodies against ADAMTS-13 in patients with thrombotic thrombocytopenic purpura bind ADAMTS-13 protease and may accelerate its clearance in vivo. J Thromb Haemost (2006) 1.15
The thrombotic microangiopathies. Pediatr Nephrol (2007) 1.01
The incidence of thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: all patients, idiopathic patients, and patients with severe ADAMTS-13 deficiency. J Thromb Haemost (2005) 2.53
Stimulation of calcium uptake in platelet membrane vesicles by adenosine 3',5'-cyclic monophosphate and protein kinase. Biochim Biophys Acta (1977) 1.97
Molecular defects in interactions of platelets with the vessel wall. N Engl J Med (1984) 1.78
Isolation of human platelet membrane microparticles from plasma and serum. Blood (1982) 1.74
Platelet surface glycoproteins. Studies on resting and activated platelets and platelet membrane microparticles in normal subjects, and observations in patients during adult respiratory distress syndrome and cardiac surgery. J Clin Invest (1986) 1.71
Drug-associated thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Curr Opin Hematol (2001) 1.50
Studies on platelet plasma membranes. IV. Quantitative analysis of platelet membrane glycoproteins by (125I)-diazotized diiodosulfanilic acid labeling and SDS-polyacrylamide gel electrophoresis. J Lab Clin Med (1978) 1.36
Evaluation of women with clinically suspected thrombotic thrombocytopenic purpura-hemolytic uremic syndrome during pregnancy. J Clin Apher (2001) 1.23
The clinical validity of normal compression ultrasonography in outpatients suspected of having deep venous thrombosis. Ann Intern Med (1998) 1.23
Drug-induced thrombocytopenia: an updated systematic review. Ann Intern Med (2001) 1.14
Incorporation of a circulating protein into megakaryocyte and platelet granules. Proc Natl Acad Sci U S A (1987) 1.14
Quinine-associated thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: frequency, clinical features, and long-term outcomes. Ann Intern Med (2001) 1.13
Remission induction in adult acute lymphocytic leukemia. Use of vincristine and prednisone alone. Cancer (1976) 1.13
Primaquine sensitivity in Caucasians: hemolytic reactions induced by primaquine in G-6-PD deficient subjects. J Lab Clin Med (1967) 1.11
Human platelet surface binding of endogenous secreted factor VIII-von Willebrand factor and platelet factor 4. Blood (1982) 1.08
Membrane changes associated with platelet activation. Exposure of actin on the platelet surface after thrombin-induced secretion. J Clin Invest (1980) 1.07
Immunoglobulin G is a platelet alpha granule-secreted protein. J Clin Invest (1985) 1.07
Platelet membrane microparticles in blood bank fresh frozen plasma and cryoprecipitate. Blood (1986) 1.06
Platelet activation and secretion associated with emotional stress. Circulation (1985) 1.05
Evidence for a Na+/K+/Cl- cotransport system in basolateral membrane vesicles from the rabbit parotid. J Membr Biol (1986) 1.05
Evaluation of bleeding and thrombotic events during long-term use of romiplostim in patients with chronic immune thrombocytopenia (ITP). J Thromb Haemost (2010) 1.04
Thrombotic thrombocytopenic purpura. Occurrence two years apart during late pregnancy in two sisters. JAMA (1976) 1.01
Occult quinine-induced thrombocytopenia. J Okla State Med Assoc (2000) 1.01
Gray platelet syndrome. Demonstration of alpha granule membranes that can fuse with the cell surface. J Clin Invest (1987) 1.00
Evidence-based medicine. Interpreting studies and setting policy. Hematol Oncol Clin North Am (2000) 0.96
Complications of plasma exchange in 71 consecutive patients treated for clinically suspected thrombotic thrombocytopenic purpura-hemolytic-uremic syndrome. Transfusion (2000) 0.95
Adhesion of human erythrocytes to glass: the nature of the interaction and the effect of serum and plasma. J Cell Physiol (1971) 0.95
Transient red blood cell aplasia in association with viral hepatitis. Occurrence four years apart in siblings. Arch Intern Med (1975) 0.95
The use of facoor VIII and factor IX concentrates during surgery. JAMA (1970) 0.94
Introducing case management to a general medicine ward team of a teaching hospital. Acad Med (1997) 0.94
Further characterization of calcium-accumulating vesicles from human blood platelets. Biochim Biophys Acta (1978) 0.93
Platelet membrane glycoproteins: alteration during storage of human platelet concentration. Thromb Res (1976) 0.93
Studies on platelet plasma membranes. II. Characterization of surface proteins of rabbit platelets in vitro and during circulation in vivo using diazotized (125i)-diiodosulfanilic acid as a label. J Lab Clin Med (1976) 0.93
Hemostatic function, survival, and membrane glycoprotein changes in young versus old rabbit platelets. J Clin Invest (1981) 0.91
Cl(-)-HCO3- exchange is present with Na+-K+-Cl- cotransport in rabbit parotid acinar basolateral membranes. Am J Physiol (1988) 0.91
Human platelets contain mRNA transcripts for platelet factor 4 and actin. Thromb Haemost (1989) 0.91
Thrombotic thrombocytopenic purpura-like syndromes following bone marrow transplantation: an analysis of associated conditions and clinical outcomes. Bone Marrow Transplant (2001) 0.90
Studies on platelet plasma membranes. I. Characterization of surface proteins of human platelets labeled with diazotized (125i)-diiodosulfanilic acid. J Lab Clin Med (1976) 0.90
Heterogeneity of platelet secretion in response to thrombin demonstrated by fluorescence flow cytometry. Blood (1987) 0.90
Cryoprecipitate poor plasma does not improve early response in primary adult thrombotic thrombocytopenic purpura (TTP). J Clin Apher (2001) 0.90
Random phosphorylation of the two heads of thymus myosin and the independent stimulation of their actin-activated ATPases. J Biol Chem (1985) 0.89
Thrombotic thrombocytopenic purpura-hemolytic uremic syndrome (TTP-HUS) following treatment with deoxycoformycin in a patient with cutaneous T-cell lymphoma (Sezary syndrome): A case report. Am J Hematol (1999) 0.88
Ionic dependence of bumetanide binding to the rabbit parotid Na/K/Cl cotransporter. J Membr Biol (1988) 0.88
Quantitative analysis of platelet membrane glycoproteins: effect of platelet washing procedures and isolation of platelet density subpopulations. Thromb Res (1982) 0.87
Endurance swimming, intravascular hemolysis, anemia, and iron depletion. New perspective on athlete's anemia. Am J Med (1986) 0.87
Thrombotic complications of antithrombotic therapy: a paradox with implications for clinical practice. Ann Intern Med (1997) 0.87
Drug-induced thrombocytopenia. Curr Opin Hematol (1999) 0.86
Topography of the external surface of the human red blood cell membrane studied with a nonpenetrating label, [125I]diazodiiodosulfanilic acid. J Biol Chem (1977) 0.86
Anion dependence of bumetanide binding and ion transport by the rabbit parotid Na(+)-K(+)-2Cl- co-transporter: evidence for an intracellular anion modifier site. Biochem J (1995) 0.86
Plasminogen activator inhibitor (PAI-1) antigen levels in primary TTP and secondary TTP post-bone marrow transplantation. Am J Hematol (1998) 0.85
An evaluation of cyclosporine alone for the treatment of early recurrences of thombotic thrombocytopenic purpura. J Thromb Haemost (2006) 0.85
Aged platelets have an impaired response to thrombin as quantitated by P-selectin expression. Blood (1994) 0.85
Acquired pure megakaryocytic aplasia report of two cases with long-term responses to antithymocyte globulin and cyclosporine. Am J Hematol (1999) 0.84
High-dose combination alkylating agent therapy with autologous bone marrow rescue for refractory solid tumors. J Clin Oncol (1988) 0.84
Studies of the mechanism of hemolysis in experimental malaria. Mil Med (1966) 0.84
Bernard-Soulier disease: a study of four patients and their parents. Br J Haematol (1981) 0.84
Predictive value of compression ultrasonography for deep vein thrombosis in symptomatic outpatients: clinical implications of the site of vein noncompressibility. Arch Intern Med (2000) 0.84
Erythrocytic abnormalities in experimental malaria. Proc Soc Exp Biol Med (1967) 0.83
Identification, characterization and purification of a 160 kD bumetanide-binding glycoprotein from the rabbit parotid. J Membr Biol (1993) 0.83
Alteration of platelet function in dogs mediated by interleukin-6. Blood (1994) 0.83
Successful non-surgical treatment of disseminated polymicrobial fungal infection in a patient with pancytopenia and graft-versus-host disease. J Infect (2000) 0.82
Hematopoietic stem cell transplantation-associated thrombotic microangiopathy: defining a disorder. Bone Marrow Transplant (2008) 0.82
Biotinylated platelets: a new approach to the measurement of platelet life span. Br J Haematol (1993) 0.81
Studies of in vitro primaquine hemolysis: substrate requirement for erythrocyte membrane damage. J Clin Invest (1966) 0.81
Evidence for two disulfide bonds important to the functioning of the renal outer cortical brush-border membrane D-glucose transporter. J Biol Chem (1983) 0.80
Solubilization and partial purification of the rabbit parotid Na/K/Cl-dependent bumetanide binding site. J Membr Biol (1990) 0.80
Studies on platelet plasma membranes. III. Membrane glycoprotein loss from circulating platelets in rabbits: inhibition by aspirin-dipyridamole and acceleration by thrombin. J Lab Clin Med (1978) 0.80
Phosphorylation of thymus myosin increases its apparent affinity for actin but not its maximum adenosinetriphosphatase rate. Biochemistry (1986) 0.80
Routine chest radiography for the evaluation of febrile neutropenic patients after autologous stem cell transplantation. Am J Hematol (2000) 0.79
Transient erythroid aplasia in hemolytic anemia: a review of the literature with two case reports. Tex Rep Biol Med (1974) 0.79
Acute bleeding and thrombocytopenia after bone marrow transplantation. Bone Marrow Transplant (2001) 0.79
Workshop on autoimmune (idiopathic) thrombocytopenic purpura: pathogenesis and new approaches to therapy. Am J Hematol (1998) 0.78
Effect of agents simulating the abnormalities of the glucose-6-phosphate dehydrogenase-deficient red cell on Plasmodium berghei malaria. Nature (1966) 0.78
Platelet IgG: measurement, interpretation, and clinical significance. Prog Hemost Thromb (1991) 0.78
Platelet behavior and aging in the circulation. Prog Clin Biol Res (1978) 0.78
Characterization of an essential disulfide bond associated with the active site of the renal brush-border membrane D-glucose transporter. Biochim Biophys Acta (1984) 0.77
Platelet membrane glycoproteins: historical perspectives. J Thromb Haemost (2005) 0.77
Inhibition of the acute-phase response in vivo by anti-gp130 monoclonal antibodies. Br J Haematol (1996) 0.77
Acute autoimmune hemolytic anemia due to a low molecular weight IgM cold hemolysin associated with episodic lymphoid granulomatous vasculitis. Am J Med (1974) 0.77
Idiopathic thrombocytopenic purpura: lessons from a guideline. Ann Intern Med (1997) 0.77
Efficacy and safety of oral granisetron versus i.v. granisetron in patients undergoing peripheral blood progenitor cell and bone marrow transplantation. Anticancer Drugs (2000) 0.77
Hereditary thrombotic thrombocytopenic purpura and the hereditary TTP registry. Hamostaseologie (2013) 0.76
Fluorescein derivatization of fibrinogen for flow cytometric analysis of fibrinogen binding to platelets. Cytometry (1994) 0.75
Initial management of immune thrombocytopenic purpura in children: is supportive counseling without therapeutic intervention sufficient? J Pediatr (2000) 0.75
Expression of the vascular endothelial growth factor receptors 1 and 2 in acute myeloid leukemia: incidence and feasibility of immunohistochemical staining. Clin Lab Haematol (2006) 0.75
Fibrinogen inhibits red cell adhesion to glass. J Cell Physiol (1972) 0.75
Glanzmann's thrombasthenia: studies of surface proteins of platelets and red cells with (125I)-diazotized diiodosulfanilic acid and SDS-polyacrylamide gel electrophoresis. Thromb Res (1981) 0.75
Long-term survival after autologous bone marrow transplantation for metastatic breast carcinoma. South Med J (1995) 0.75
Autologous bone marrow transplantation for non-Hodgkin lymphoma. J Okla State Med Assoc (1994) 0.75
Cytomegalovirus surveillance and prevention in allogeneic bone marrow transplantation: examination of a preemptive plan of ganciclovir therapy. Am J Hematol (1996) 0.75
Autologous bone marrow transplantation for metastatic breast cancer. J Okla State Med Assoc (1994) 0.75
Long-term results of autologous marrow transplantation for relapsed or refractory male or female germ cell tumors. Bone Marrow Transplant (1998) 0.75
Histiocytic medullary reticulosis with parallel increases in serum acid phosphatase and disease activity. Cancer (1976) 0.75
Leukaemoid reactions in myeloproliferative diseases. Report of two patients. Scand J Haematol (1975) 0.75
Problems in separation of small numbers of platelets from unbound ligands. Thromb Res (1986) 0.75
Marrow and stem cell transplantation in Oklahoma: fifteen years of experience and results. J Okla State Med Assoc (1998) 0.75
Unintentional platelet removal by plasmapheresis. J Clin Apher (2001) 0.75
High-dose carboplatin, etoposide and cyclophosphamide with autologous bone marrow transplantation for the treatment of advanced malignancies: a phase I study. Bone Marrow Transplant (1995) 0.75